B. James Tananbaum

Affiliations

  • Insider at Latigo Biotherapeutics Inc. (LTGO), 2026-08-11
  • Large Shareholder, Director at Alumis Inc. (ALMS), 2026-04-03
  • Insider at Kinnate Biopharma Inc. (KNTE), 2024-04-05
  • President and Ceo at Pardes Biosciences Inc. (PRDS), 2023-08-31
  • Large Shareholder at Theseus Pharmaceuticals Inc. (THRX), 2023-07-19
  • Large Shareholder at Aclaris Therapeutics Inc. (ACRS), 2021-11-03
  • Large Shareholder, Director at Gemini Therapeutics Inc. (GMTX), 2021-10-06
  • Director at Quantum-Si Inc (QSI), 2021-06-14
  • Large Shareholder at 10X Genomics Inc. (TXG), 2020-05-14
  • Large Shareholder at Aerie Pharmaceuticals Inc (AERI), 2020-03-02
  • Large Shareholder at Aimmune Therapeutics Inc. (AIMT), 2016-08-19
  • Large Shareholder at Intellia Therapeutics Inc. (NTLA), 2016-05-05
  • Large Shareholder at Ambit Biosciences Corp (AMBI), 2013-10-16
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
LTGO $18.00 140,000 $2,520,000.00 2,008,024 2026-08-10 Filing
ALMS $17.00 294,117 $4,999,989.00 2,908,332 2026-01-08 Filing
ALMS $17.00 117,647 $1,999,999.00 5,702,536 2026-01-08 Filing
ALMS $7.38 72,212 $532,924.56 2,614,215 2025-11-21 Filing
ALMS $6.56 190,500 $1,249,680.00 2,542,003 2025-11-19 Filing